skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. AIDR: Wondering what your current thoughts would be on this early stage company. [Rocket Doctor AI Inc.]
You can view 0 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Wondering what your current thoughts would be on this early stage company. It looks like they have some interesting clients.
Thank you!
Asked by Robert on February 11, 2026
5i Research Answer:

AIDR is quite small at $68M market cap, after a 21% gain in the past year. It provides healthcare software solutions. Essentially, an AI doctor. But, currently it has minimal revenue ($1M), losses and negative cash flow. Fundamental Research did start coverage on the company. It does have some partnerships with insurance companies, with large numbers of members, so there is some potential here. But we need to see some sales in order to gauge what future profitability might be. There is competition in the space, certainly, as well. Insiders own 4.5%. While interesting, we would consider it too early here.